Skip to content
Abierto
Menu

Award notice, first published as presolicitation

Injectable Egg-Free Influenza Vaccine

SPE2DP-24-R-0006

Defense Logistics Agency, DLA Troop Support. Biological Product (except Diagnostic) Manufacturing.

View on SAM.govMarkdown

Awarded

Seqirus USA Inc.

$0.00 obligated so far on USAspending

Description

As published on SAM.gov with the solicitation of October 18, 2024.

Injectable Egg-Free Influenza Vaccine Solicitation SPE2DP-24-R-0006

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Seqirus USA Inc.
UEI
N6U7P2B9VHS5
CAGE
530P3
Vendor location
Summit, NJ
Contract
SPE2DP25D0004
Obligated
$0.00, potential $6,857,676
Actions
2 between February 14, 2025 and May 1, 2025
Competition
Full and Open Competition, 3 offers received
Set-aside reported
No Set Aside Used.
Described as
4610118532!influenza Virus Vac
Match
award number SPE2DP25D0004 equals the contract number; same awarding office SPE2DP (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. July 22, 2024

    Presolicitation

    Due August 22, 2024 at 3:00 PM EDT. SAM.gov, notice 2092cc730288461798e14bf87a23b8ce

  2. October 2, 2024

    Presolicitation

    Due October 17, 2024 at 3:00 PM EDT. SAM.gov, notice 4cfbce3847904a60b8671336e8abed20

  3. October 2, 2024

    Presolicitation

    Due October 17, 2024 at 3:00 PM EDT. SAM.gov, notice 90962d3ece594031b59ad515dd2c7cca

  4. October 18, 2024

    Solicitation, originally presolicitation

    Due November 12, 2024 at 3:00 PM EST. SAM.gov, notice f2bee44811104a51a44baecd289f0b9b

  5. April 25, 2025

    Award notice, originally solicitation

    Awarded to SEQIRUS USA Inc. Summit for $6,857,676. SAM.gov, notice bf4a42cafcae4d249e36d1b8daa409c2

Points of contact

Also open from this buyer